Improving Biomarker Driven Precision Therapy in NSCLC: Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC September 29, 2021
Improving Biomarker Driven Precision Therapy in NSCLC: The Importance of an Integrated Multidisciplinary Approach Part 2 - Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC
Category
  • Hematology/Oncology
Format
  • Conference / meeting
  • Online live
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation